For international orders please contact the appropriate distributor for your country.
Preferred Cell Systems™ welcomes the opportunity to work with distributors around the world.
At the present time, Preferred Cell Systems™ is proud to distribute its assay kit product line through the following companies.
European-Wide Distributor: Trinova Biochem GmbH
Rathenau Str. 2
Tel: 49 641-94390-0
Fax: 49 641-94390-22
Austria, Slovakia & Croatia
Distributor: Anopoli Biomedical Systems
Tel: 43 2773 42564
Fax: 43 2773 44393
Australia and New Zealand
Distributor: Australia Biosearch
Address: P.O. Box 86
Karrinyup, WA 6921
Tel. Toll Free: 800-858-797
Offices in Perth, Sydney & Melbourne
Distributor: BARIA s.r.o.
Contact: Ing. Jena Kopecka
252 44 Psary
Tel/Fax: 420 323 550 123
Dubai and the Middle East
Distrubutor: Intelli Laboratories Trading LLC
Al Quasais Industrial Area 3
P.O. Box 239775
Dubai - UAE
Tel: 971 4 548 0211
Cell/Mobile: 971 55 999 6592
Contact: Amr Aly, email@example.com
Distributor: Universal Biologicals
Papworth St. Agnes
Cambridge CB23 3QU
Tel: 44 1480 839 015
Fax: 44 1480 831 912
Distributor: CellBios Healthcare & Lifesciences
No. 1/7 First Floor
Poonamallee High Road
600 095 Tamil Nadu
Tel: 91 44 2476 5300
91 44 2476 7027
Fax: 91 44 2476 7037
Distributor: Biogenuix Medsystems Pvt. Ltd.
Address: 412-B, 4th Floor,
Jyoti Shikhar Towers District Center,
Tel: 91 11 25612008
Fax: 91 11 45513884
Contact: Ashish Bawa
Distributor: BioTag Ltd.
P.O. Box 4067
Distributor: Cosmo Bio Co., Ltd.
Toyo Ekimae Bldg.
2-2-0 Toyo, Koto-ku
Tel: 81 (0) 3-5632-9608
Fax: 81 (0) 3-5632-9965
Distributor: Nacalai Tesque
Nijo Karasuma, Nakagyo-ku
The Netherlands, Luxenbourgh, Switzerland, Poland, Hungary, Lithuania, Estonia, Letland, Sweden, Norway, Denmark, Finland
Distributor: Divbio Science Europe
P.O. Box 92
4850 AB Ulvenhout
Tel: 31 76 565 1680
Fax: 31 76 201 1229
Distributor: DivBioScience Africa
7 Bright Street
Somerset West 7130
Tel: 72 956 5818
Fax: 800 982 260
19F, IS BIZ Tower,
Yangpyeong-ro 21 gil 26,
Distributor: Integrated Bio Ltd.
6F-3, No. 800 Xongzheng Road
New Taipai City 23586
50 Years of Colony-Forming Assays for Hematopoietic Stem and Progenitor Cells: A Comparison and the Future
December 2016. Download the Application Note.
"Stem Cells and Predictive In Vitro Toxicity Testing".
November, 2011. Download the White Paper here.
Stem Cell Potency White Papers
CFU and HALO Cost-Analysis White Paper
April 2010: A Cost-Analysis of Colony-Forming Assays and Equivalent Alternatives used to Determine Growth of Hematopoietic Cells Derived from Umbilical Cord Blood, Normal and Mobilized Peripheral Blood and Bone Marrow.
"A Stem Cell Potency and Release Criteria Assay Specifically Designed for Umbilical Cord BloodCord Transplantation that is Compliant With Regulatory Guidelines" presented at the International Society of Cellular Therapy (ISCT), San Diego, CA 2009
"A Novel Stem, Cell Potency and Release Assay for Umbilical Cord Blood: Correlation of Stem Cell Proliferation with Engraftment" presented at the International Society of Cellular Therapy (ISCT), May 2008 in Miami, FL
"Proliferation Assays Provide Non-Subjective and Standardized Alternatives for Assessing the Potency of Stem Cell Products for Storage and Transplantation" presented at the International Society of Cellular Therapy (ISCT), Sydney, Australia, June 2007
"A Novel Assay to Evaluate the Functional Potential of Umbilical Cord Blood Progenitor" presented at the International Society of Cellular Therapy (ISCT), Sydney, Australia,June 2007
"Erythropoietin Protects Cells from Oxidative Stress by Reducing Oxidative DNA Damage" presented at the Society of Toxicology Meeting in Charlotte, North Carolina in March 2007
A Standardized Protocol to Assess Stem Cell Potency. Steffen Porwolik. SamplingScience Blog. January 29, 2015. Link: http://www.biocision.com/blog/11485/assessing-stem-cell-potency.
Predicting Organ Toxicity In Vitro: Bone Marrow. Ivan N. Rich and Adrew J. Olaharski. In: Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers. 1st Edition. Eds. Yvonne Will, J Eric McDuffie, Andrew J. Olaharski and Branson D. Jeffy. Jon Wiley & Sons. (2016).
Bioluminescence Potency Measurement opf Cellular Therapy Products. Hilli Harper and Ivan N. Rich. In: Cellular Therapy: Principles, Methods, and Regulations. 2nd Edition. Eds. Ellen Areman and Kathy Loper. AABB (2016).
Measuring Stem Cell Circadian Rhythm. William Hrushesky and Ivan N. Rich. In: Stem Cell Protocols, Ed: Ivan N. Rich. Human Press (2015).
Measuring the Potency of a Stem Cell Therapeutic. Ivan N. Rich. In: Stem Cell Protocols, Ed: Ivan N. Rich. Human Press (2015).
Measurement of Hematopoietic Stem Cell Proliferation, Self-Renewal and Expansion Potential. Ivan N. Rich. In: Stem Cell Protocols, Ed: Ivan N. Rich. Human Press (2015).
A Short Primer in Stem Cell Biology. Ivan N. Rich. In: Stem Cell Protocols, Ed: Ivan N. Rich. Human Press (2015).
Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective, by Ivan N. Rich. Stem Cells Translational Medicine. First published on July 9, 2015; DOI 10.5966/sctm.2015-0036. Available at: http://stemcellstm.alphamedpress.org/content/early/2015/07/09/sctm.2015-0036.full.pdf+html
Detecting Primitive Hematopoietic Stem Cells in Total Nucleated and Mononuclear Cell Fractions from Umbilical Cord Blood Segments and Units, by John Patterson, Calli H. Moore, Emily Palser, Jason C. Hearn, Daniela Dumitru, Holli A. Harper and Ivan N. Rich. Journal of Translational Medicine (2015) 13:94. DOI 10.1186/s12967-015-0434-z. Available at: http://www.translational-medicine.com/content/13/1/94.
Present Cord Blood Testing Fails to Determine if the Stem Cells Used for Transplantation are of High Quality and Potency, by Ivan N. Rich. On The Parents Guide to Cord Blood Foundation wbsite. Available at: http://parentsguidecordblood.org/en/news/present-cord-blood-testing-fails-determine-if-stem-cells-used-transplantation-are-high-quality
Potency, Proliferation and Engraftment Potential of Stem Cell Therapeutics: The Relationship between Potency and Clinical Outcome for Hematopoietic Stem Cell Products. Published as an Open Access review article in J. Cell Science & Therapy (2013, S13).
The Difference Between Stem Cell Viability and Potency: A Short Guide for Parent and Patients, by Ivan N. Rich. On The Parents Guide to Cord Blood Foundation website. Available at: http://parentsguidecordblood.org/en/news/difference-between-stem-cell-viability-and-potency-short-guide-parents-and-patients.
Stem Cell Predictive Hemotoxicology, by Holli Harper and Ivan Rich, (2013). Stem Cell Predictive Hemotoxicology, Stem Cell Biology in Normal Life and Diseases, Prof. Kamran Alimoghaddam (Ed.), ISBN: 978-953-51-1107-8, InTech, Available from: http://www.intechopen.com/books/stem-cell-biology-in-normal-life-and-diseases/stem-cell-predictive-hemotoxicology.
Hematopoietic Stem Cell Potency for Cellular Therapeutic Transplantation, by Hall KM, Harper H, & Rich IN. In: Hematopoietic Stem Cell Research,
Full reference: Karen M. Hall, Holli Harper and Ivan N. Rich (2012). Hematopoietic Stem Cell Potency for Cellular Therapeutic Transplantation, Advances in Hematopoietic Stem Cell Research, Rosana Pelayo (Ed.), ISBN: 978-953-307-930-1, InTech, Available from: http://www.intechopen.com/articles/show/title/hematopoietic-stem-cell-potency-for-cellular-therapeutic-transplantation
This is the first definitive article on how hematopoietic stem cell potency is measured.
Cellular Therapy: Principles, Methods and Regulations. Eds. Areman EM, Loper K. 2009 pp. 581-591
"Bioluminescence Assays for Assessing Potency of Cellular Therapy Products".
A article describing how cord blood potency is measured using HALO®-96 PQR.
"In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates".
Demonstrates that HALO® provides greater than 80% concordance with in vivo results.
"In vitro hematotoxicity testing in drug development: A review of past, present and future applications".
Demonstrates how HALO® correlates with the colony-forming cell (CFC) assay and why HALO can be performed more rapidly than the CFC assay.
"High-throughput in vitro hemotoxicity testing and in vitro cross-platform comparative toxicity".
This article describes the drawbacks of the colony-forming assay technique in hemotoxicity testing, development and descriptions of the HALO® Platforms, validation of the HALO® platforms against the colony-forming assay, predicting hemotoxicity and the ComparaTOX™ Platform for in vitro cross-platform comparative toxicity testing. Please contact HemoGenix®.
"Validation and Development of a Predictive Paradigm for Hemotoxicology using a Multifunctional Bioluminescence Colony-Forming Proliferation Assay".
"Standardization of the CFU-GM Assay using Hematopoietic Growth Factors".
"Diesel exhaust influences carcinogenic PAH-induced genotoxicity and gene expression in human breast epithelial cells in culture" by L.A.Couter, C. Pereira and W.M. Baird.
This articles uses the OxyFLOW™ Platform to measure oxidative DNA damage.